Search Results - "tyrosine kinase"

Pseudoangiosarcoma and cutaneous collagenous vasculopathy in a patient on a Bruton's tyrosine kinase inhibitor by Alison H. Kucharik, MD, Nina B. Curkovic, BS, Julio C. Chavez, MD, Kenneth Y. Tsai, MD, PhD, Andrew S. Brohl, MD, James M. Grichnik, MD, PhD

Connect to this object online.

Tyrosine kinase inhibitors for EGFR- and ALK-mutated non-small cell lung cancer by Jonathan R. Thompson, Smitha P. Menon, Grace K. Dy

Connect to this object online.

The Possible Role of Bruton Tyrosine Kinase Inhibitors in the Treatment of COVID-19: A Review by Mitra Rezaei, MD, Saghar Barati, Pharm-D, PhD, Abdolreza Babamahmoodi, MD, Farzaneh Dastan, Pharm-D, PhD, Majid Marjani, MD

Connect to this object online.

ABCB1 haplotypes do not influence transport or efficacy of tyrosine kinase inhibitors in vitro by Skoglund K, Boiso Moreno S, Baytar M, Jönsson JI, Gréen H

Connect to this object online.

Inhibition of Spleen Tyrosine Kinase Restores Glucocorticoid Sensitivity to Improve Steroid-Resistant Asthma by Qian Liu, Lijuan Hua, Chen Bao, Luxia Kong, Luxia Kong, Jiannan Hu, Chao Liu, Ziling Li, Shuyun Xu, Xiansheng Liu

Connect to this object online.

The Status Quo of Pharmacogenomics of Tyrosine Kinase Inhibitors in Precision Oncology: A Bibliometric Analysis of the Literature by Abdallah Alzoubi, Hassan Shirazi, Ahmad Alrawashdeh, Arwa M. AL-Dekah, Nadia Ibraheem, Khalid A. Kheirallah

Connect to this object online.

The expression of COX-2 in VEGF-treated endothelial cells is mediated through protein tyrosine kinase by Pravit Akarasereenont, Kitirat Techatraisak, Athiwat Thaworn, Sirikul Chotewuttakorn

Connect to this object online.

Immunohistochemical Evaluation and Clinicopathological Correlation of Mer and Axl Tyrosine Kinase TAM Receptors in Cutaneous Melanoma by Andrea Pontara, Giovanni Paolino, Vanesa Gregorc, Santo Raffaele Mercuri, Alessandra Bulotta, Pietro Bearzi, Claudio Doglioni, Nathalie Rizzo

Connect to this object online.

Novel biomarkers used for early diagnosis and tyrosine kinase inhibitors as targeted therapies in colorectal cancer by Huafeng Jiang, Senjun Zhou, Gang Li

Connect to this object online.

<i>In Vitro</i> and <i>In Vivo</i> Inhibition of MATE1 by Tyrosine Kinase Inhibitors by Muhammad Erfan Uddin, Zahra Talebi, Sijie Chen, Yan Jin, Alice A. Gibson, Anne M. Noonan, Xiaolin Cheng, Shuiying Hu, Alex Sparreboom

Connect to this object online.

Evaluation of Serum Soluble fms-like Tyrosine Kinase-1 as a Biomarker in Ectopic Pregnancy by Alaa Raeed, Aseel Ghazi Rifat

Connect to this object online.

Cost-Effectiveness Analysis of Tyrosine Kinase Inhibitors in Gastrointestinal Stromal Tumor: A Systematic Review by Mingyang Feng, Mingyang Feng, Yang Yang, Yang Yang, Weiting Liao, Weiting Liao, Qiu Li, Qiu Li

Connect to this object online.

An overview on the role of FLT3-tyrosine kinase receptor in acute myeloid leukemia: biology and treatment by Tiziana Grafone, Michela Palmisano, Chiara Nicci, Sergio Storti

Connect to this object online.

Preclinical pharmacokinetic evaluation to facilitate repurposing of tyrosine kinase inhibitors nilotinib and imatinib as antiviral agents by Hari Krishna Ananthula, Scott Parker, Erin Touchette, R. Mark Buller, Gopi Patel, Daniel Kalman, Johanna S. Salzer, Nadia Gallardo-Romero, Victoria Olson, Inger K. Damon, Tessa Moir-Savitz, Larry Sallans, Milton H. Werner, Catherine M. Sherwin, Pankaj B. Desai

Connect to this object online.

Overcoming EGFR T790M-based Tyrosine Kinase Inhibitor Resistance with an Allele-specific DNAzyme by Wei-Yun Lai, Chi-Yuan Chen, Shuenn-Chen Yang, Jer-Yuarn Wu, Cheng-Ju Chang, Pan-Chyr Yang, Konan Peck

Connect to this object online.

Receptor tyrosine kinase (c-Kit) inhibitors: a potential therapeutic target in cancer cells by Abbaspour Babaei M, Kamalidehghan B, Saleem M, Huri HZ, Ahmadipour F

Connect to this object online.

Inhibition of Xanthine Oxidoreductase Enhances the Potential of Tyrosine Kinase Inhibitors against Chronic Myeloid Leukemia by Marta Romo-González, Sara Moreno-Paz, Violeta García-Hernández, Fermín Sánchez-Guijo, Ángel Hernández-Hernández

Connect to this object online.

Pharmacogenomics of Impaired Tyrosine Kinase Inhibitor Response: Lessons Learned From Chronic Myelogenous Leukemia by Meike Kaehler, Ingolf Cascorbi

Connect to this object online.

Tyrosine Kinase Inhibitors Are Promising Therapeutic Tools for Cats with HER2-Positive Mammary Carcinoma by Andreia Gameiro, Filipe Almeida, Catarina Nascimento, Jorge Correia, Fernando Ferreira

Connect to this object online.

Bosutinib: a SRC&ndash;ABL tyrosine kinase inhibitor for treatment of chronic myeloid leukemia by El Rassi F, Khoury HJ

Connect to this object online.